$BRKR News

The 5 Most Interesting Analyst Questions From Bruker’s Q2 Earnings Call

Bruker (BRKR) Q2 2026 Earnings Call Transcript

Bruker Announces Strategic Collaboration with Atinary Technologies to Advance Self-Driving Laboratories

Bruker Announces Majority Investment in MIMETAS to Advance Human Physiology-Relevant Drug Discovery and Development

Is Bruker (BRKR) Fairly Valued After Its 52 Week High?

Citigroup Maintains Neutral on Bruker, Lowers Price Target to $53

Weak Growth In Its Primary Market Continues To Weigh Heavily On Bruker Shares

Bruker (BRKR) Is Down 20.0% After Goodwill Impairment-Fueled Q2 Loss Despite Higher Sales

Bruker (BRKR) Could Be 16% Below Fair Value On Q2 Results And 2026 Guidance

Bruker Corporation Q2 2026 Earnings Call Summary

Bruker Corp (BRKR) (Q2 2026) Earnings Call Highlights: Organic Growth Returns, Margins Surge, ...

Bruker Reports Second-Quarter 2026 Results as Scientific Instruments Bookings Accelerate

Bruker Q2 Earnings Call Highlights

Bruker (BRKR) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Bruker (BRKR) Q2 Earnings Beat Estimates

Bruker (NASDAQ:BRKR) Reports Sales Below Analyst Estimates In Q2 CY2026 Earnings, Stock Drops 11.9%

Bruker Reports Second Quarter 2026 Financial Results

Bruker Affirms FY2026 Adj EPS Guidance of $2.10-$2.15 vs $2.12 Est; Lowers FY2026 Sales Guidance from $3.570B-$3.600B to $3.540B-$3.570B vs $3.589B Est

Bruker Q2 Adj. EPS $0.49 Beats $0.39 Estimate, Sales $838.500M Miss $853.543M Estimate

Earnings To Watch: Bruker (BRKR) Reports Q2 Results Tomorrow